Papers
11
Total Citations
105
H-Index
4
About
Shlomi Rayman is a leading figure in the advancement of robotic surgery for complex hepatobiliary, pancreatic, and esophageal procedures. His research focuses on rigorously comparing robotic approaches to traditional laparoscopic and open techniques, with a particular emphasis on clinical outcomes, oncological survival, and cost-effectiveness. Dr. Rayman’s major contributions include demonstrating the safety and efficacy of robotic left and extended left hepatectomy through a large international multicenter study, which has garnered 57 citations, and providing critical cost analyses for robotic transhiatal esophagectomy. He has also pioneered the use of robotic-assisted biliary tract reconstruction for benign disease and developed the Tampa difficulty score, a novel system to stratify the complexity of robotic pancreaticoduodenectomy. His work on the impact of metabolic syndrome and BMI on robotic surgery outcomes further underscores his commitment to personalized surgical care. With over 100 citations across his most-cited works, Dr. Rayman’s research is instrumental in defining the role of robotics in modern surgery, making him a key voice in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2Evaluating the Cost for Robotic vs “Non-Robotic” Transhiatal Esophagectomy10 citations · 2021
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10